PTCT FY 2025 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$6B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.7B+114.5% YoY

Gross Profit

$1.7B95.9% margin

Operating Income

$857M49.5% margin

Net Income

$683M39.4% margin

EPS (Diluted)

$7.78

Cash Flow

Operating Cash Flow

$711M

Free Cash Flow

$702M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.9B

Total Liabilities

$3.1B

Stockholders' Equity

-$205M

Cash & Equivalents

$985M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$807M	+114.5%
Gross Profit	$1.7B	$749M	+121.4%
Operating Income	$857M	-$303M	+383.1%
Net Income	$683M	-$363M	+287.9%